🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Biomark Diagnostics Inc. (FRA:20B)
Germany flag Germany · Delayed Price · Currency is EUR
0.2440
+0.0060 (2.52%)
Last updated: Nov 17, 2026, 3:32 PM CET

Biomark Diagnostics Ratios and Metrics

Millions EUR. Fiscal year is Apr - Mar.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
263614171011
Market Cap Growth
29.44%148.17%-15.29%61.96%-7.18%-45.46%
Enterprise Value
263515181212
Last Close Price
0.240.340.140.190.130.14

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PS Ratio
1516.13961.85145.04152.12100.50356.91
PB Ratio
73.80173.7012.85-40.73-13.42-24.67
P/TBV Ratio
73.80173.7012.85---

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
EV/Sales Ratio
-952.24154.52161.35110.73393.16

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Debt / Equity Ratio
2.234.290.64-2.54-1.44-3.09
Net Debt / Equity Ratio
0.851.24-0.78-2.28-1.37-2.49
Net Debt / EBITDA Ratio
-0.28-0.240.67-0.82-0.86-1.24
Net Debt / FCF Ratio
-0.45-0.371.24-1.41-1.72-1.25
Asset Turnover
0.010.020.070.180.140.04
Quick Ratio
1.260.972.140.160.060.31
Current Ratio
1.290.992.140.160.080.33
Return on Equity (ROE)
-149.87%-142.59%-340.70%---
Return on Assets (ROA)
-45.63%-43.06%-60.59%-117.29%-104.38%-66.20%
Return on Capital Employed (ROCE)
-117.50%-225.70%-107.60%1099.30%197.40%4328.70%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Earnings Yield
-3.42%-2.57%-8.62%-5.75%-11.94%-9.27%
FCF Yield
-2.53%-1.90%-4.90%-3.98%-5.96%-8.06%
Buyback Yield / Dilution
-11.57%-15.58%-6.67%-2.97%-6.22%-6.31%